Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Isoprinosine in HIV Patients With Viral Load Between 50 and 200 Copies/mL
NCT03883334Phase 4Unknown
- Sponsor
- Universidad San Francisco de Quito
- Start
- Feb 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of inosine pranobex in human immunodeficiency virus infection (HIV), sponsored by Universidad San Francisco de Quito. Status: unknown.
02
Drugs
inosine pranobex
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03883334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03883334.